| Market Cap | ₹2,160Cr |
| ROE | 9.16% |
| P/E Ratio(TTM) | 26.87 |
| EPS(TTM) | 24.78 |
| P/B Ratio | 2.34 |
| Dividend Yield | 0.41% |
| Industry P/E | 56.91 |
| Book Value | 284.52 |
| Debt to Equity | 0.31 |
| Face Value | 5 |
| Managing Director | Pallavi Bhatevara |
| Founded | 2010 |
| NSE Symbol | KRSNAA |
| FUND NAME | AUM(%) |
|---|---|
| Tata Small Cap Fund Direct Growth | 1.70% |
| Bandhan Small Cap Fund Direct Growth | 0.23% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 44.70 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 64.84 | ||
| Metropolis Healthcare | NA (0.00%) | 59.24 | ||
| Thyrocare Technologies | NA (0.00%) | 47.68 |